direct
chemoselect
differenti
function
ringc
hydroxyl
group
present
amaryllidacea
alkaloid
lycorin
describ
allow
select
manipul
group
minilibrari
compris
synthet
natur
lycoran
alkaloid
prepar
apoptosisinduc
activ
investig
human
leukemia
jurkat
cell
insight
natur
interest
apoptosisinduc
pharmacophor
describ
includ
requir
free
hydroxyl
group
ringc
three
major
structur
distinct
class
amaryllidacea
alkaloid
recogn
lycoran
galanthamin
crinan
type
jin
sever
less
common
structur
variant
also
known
kornienko
evident
structur
type
relat
consequ
common
biogenesi
amino
acidderiv
precursor
norbelladin
scheme
repres
major
seri
includ
lycorin
galanthamin
crinamin
respect
illustr
remark
structur
divers
natur
evolv
plethora
biolog
properti
exhibit
compound
surprisingli
equal
divers
bastida
et
al
galanthamin
class
galanthamin
first
amaryllidacea
alkaloid
approv
pharmaceut
treatment
human
diseas
remark
abil
revers
inhibit
acetylcholinesteras
relev
alzheim
neurodegen
diseas
recent
led
approv
prescript
drug
gener
name
reminyl
houghton
et
al
alkaloid
crinan
seri
shown
exhibit
rang
biolog
activ
tram
et
al
exampl
crinamin
known
cytotox
malari
parasit
seri
tumor
cell
line
likhitwitayawuid
et
al
activ
mous
melanoma
cell
document
haemanthamin
epim
crinamin
known
inhibit
protein
synthesi
antiprolif
action
jimenez
et
al
hohmann
et
al
recent
demonstr
potent
apoptosisinduc
abil
aethano
bridg
crinan
alkaloid
crinamin
epimer
haemanthamin
compound
shown
significantli
activ
bethano
bridg
compound
mcnulti
et
al
mcnulti
et
al
demonstr
critic
structur
requir
vicin
cring
lycoran
seri
pancratistatin
analogu
narciclasin
kornienko
evident
known
potent
select
anticanc
properti
well
synthet
challeng
structur
synthet
effort
area
involv
complementari
pair
approach
pharmacophor
minim
mcnulti
mo
mcnulti
et
al
mcnulti
et
al
mcnulti
et
al
mcnulti
et
al
rinner
hudlicki
disclos
strict
requir
free
hydroxyl
group
ringc
compound
potent
apoptosisinduc
activ
shown
pancratistatin
induc
apoptosi
select
cancer
cell
minim
effect
normal
cell
mitochondria
site
action
mclachlan
et
al
evid
apoptot
mode
death
cancer
cell
relat
earli
activ
follow
flip
phosphatidyl
serin
interest
structur
requir
apoptosisinduc
activ
pancratistatintyp
lycoran
deriv
drew
attent
alkaloid
lycorin
subclass
lycorin
far
common
alkaloid
within
amaryllidacea
famili
compound
exhibit
vast
array
biolog
properti
activ
polioviru
hwang
et
al
vaccinia
smallpox
viru
deng
et
al
sarsassoci
coronaviru
li
tan
furthermor
exhibit
antifung
activ
saccharomyc
cerevisia
del
giudic
et
al
fatal
protozoan
parasit
trypanosoma
brucei
mackey
et
al
potent
indomethacin
antiinflammatori
agent
citoglu
et
al
addit
lycorin
shown
insect
antifeed
activ
evident
et
al
inhibit
ascorb
acid
biosynthesi
arrigoni
et
al
inhibit
enzym
acetylcholinesteras
signific
motor
neuron
diseas
lopez
et
al
fact
inhibitori
effect
toward
cell
divis
cell
elong
plant
suggest
may
inhibit
either
rna
protein
synthesi
de
leo
et
al
jimenez
et
al
potenti
chemotherapeut
shown
promis
antiprolif
agent
number
cancer
cell
line
likhitwitayawuid
et
al
investig
vitro
mode
action
leukemia
cell
line
model
establish
lycorin
suppress
tumor
cell
growth
reduc
cell
surviv
via
cell
cycl
arrest
induct
apoptosi
liu
et
al
investig
effect
lycorin
sever
combin
immunodefici
scid
mice
inocul
cell
show
decreas
tumor
cell
growth
increas
surviv
rate
observ
advers
effect
treat
anim
arrest
cell
cycl
progress
apoptosi
induct
also
demonstr
mechan
action
lycorin
multipl
myeloma
cell
motiv
interest
divers
biolog
properti
decid
investig
structureact
studi
lycorineseri
order
refin
pharmacophor
requir
herein
describ
concis
chemoand
regioselect
threestep
synthesi
lycorin
util
reactiv
allyl
pseudoequatori
hydroxi
group
select
function
allow
us
prepar
minilibrari
lycorin
deriv
analogu
scheme
investig
apoptosisinduc
properti
six
deriv
show
lycorin
pseudolycorin
abl
induc
apoptosi
human
leukemia
jurkat
cell
micromolar
level
previou
studi
highlight
difficulti
attend
differenti
function
hydroxyl
group
present
within
lycorin
seri
takeda
et
al
previou
work
group
shown
highli
select
monosilyl
achiev
certain
condit
mcnulti
mao
reaction
lycorin
tertbutyldimethylsilyl
chlorid
tbscl
pyridin
dichloromethan
dcm
scheme
therefor
investig
delight
reaction
afford
novel
monosilyl
ether
yield
like
due
greater
reactiv
allyl
pseudoequatori
group
axiallyorient
hydroxyl
h
nmr
spectrum
see
section
signal
dd
upfieldshift
dd
reson
lycorin
cosi
contour
establish
dd
dd
addit
threebond
hmbc
show
correl
direct
access
allow
us
prepar
new
allyl
acet
obtain
near
quantit
yield
silyl
ether
upon
acetyl
acet
anhydrid
pyridin
h
nmr
spectrum
show
expect
deshield
effect
dd
desilyl
proceed
smoothli
tetrabutylammonium
fluorid
tbaf
tetrahydrofuran
thf
give
proton
spectrum
indic
slight
upfield
shift
dd
compar
whose
spectroscop
data
mpt
ir
h
nmr
c
nmr
similar
literatur
valu
kobayashi
et
al
acetyl
provid
isol
yield
signal
dd
spectroscop
data
close
agreement
document
valu
kobayashi
et
al
minipanel
synthet
compound
togeth
natur
product
lycorin
pseudolycorin
screen
abil
induc
apoptosi
human
leukemia
jurkat
lm
analogu
exhibit
indic
control
level
nuclear
morpholog
chang
characterist
apoptosi
visual
hoechst
stain
fig
condens
nuclei
cell
affect
treatment
fluoresc
fragment
appear
parallel
hoechst
stain
cell
also
treat
trypan
blue
evalu
extent
necrot
cell
subject
annexinv
bind
assay
indic
induct
program
cell
death
data
shown
mild
activ
exhibit
indic
small
substitu
partli
toler
overal
clear
result
free
ringc
requir
lycorin
seri
lycorin
pseudolycorin
potent
apoptosisinduc
activ
sinc
monosubstitut
silyl
ether
well
disubstitut
analogu
inact
present
studi
apoptosi
initi
retain
upon
replac
group
lycorin
substitu
pseudolycorin
contrast
observ
rinner
et
al
substitut
methylenedioxi
group
pancratistatin
led
drop
activ
intriguingli
phenanthridin
nucleu
common
crinan
lycorin
pancratistatin
seri
compound
n
ethano
bridg
common
crinan
compound
n
ethyl
tether
characterist
lycorin
compound
present
result
also
draw
attent
subtl
often
critic
natur
region
around
ring
junction
crinan
alkaloid
seri
apoptosisinduc
abil
aseri
far
supersed
bseri
mcnulti
et
al
mcnulti
et
al
case
examin
presenc
doubl
bond
pancratistatin
seri
narciclasin
known
detriment
effect
anticanc
activ
profil
rinner
hudlicki
also
demonstr
mildli
modul
influenc
doubl
bond
acrinan
compound
mcnulti
et
al
mcnulti
et
al
introduct
sp
hybrid
carbon
ring
junction
appear
introduc
minor
conform
effect
pharmacophor
doubl
bond
lycorin
may
play
similar
conform
role
crinan
pancratistatin
seri
sinc
dihydrolycorin
deriv
also
shown
possess
activ
jimenez
et
al
overal
result
fig
superfici
appear
reminisc
strict
requir
apoptosi
induct
pancratistatin
minimum
three
free
hydroxyl
ring
c
necessari
activ
howev
group
present
lycorin
show
requir
activ
opposit
absolut
configur
analog
posit
found
pancratistatin
furthermor
ring
junction
lycorin
also
opposit
configur
found
pancratistatin
given
strict
requir
ringc
hydroxyl
group
known
activ
pancratistatin
seri
remark
note
entpancratistatin
deriv
also
shown
slightli
reduc
anticanc
activ
hudlicki
et
al
remov
singl
hydroxyl
group
may
result
inact
compound
chang
absolut
configur
entir
molecul
result
retent
activ
result
demonstr
import
high
sensit
ringc
region
modul
cytotox
heighten
possibl
compound
pancratistatin
entpancratistatin
narciclasin
also
lycorin
may
act
upon
biolog
receptor
conclus
demonstr
select
monosilyl
hydroxyl
group
alkaloid
lycorin
work
allow
synthesi
minilibrari
differenti
function
lycorin
deriv
biolog
assay
compound
demonstr
free
pharmacophor
requir
induct
apoptosi
lycorin
seri
comparison
drawn
activ
demonstr
pancratistatinentpancratistatin
structur
type
may
indic
common
pharmacophor
draw
attent
critic
natur
ringc
region
stereochemistri
function
subtleti
manifest
structureact
studi
biolog
assay
aim
elucid
mechan
action
deriv
progress
laboratori
base
structur
similar
activ
compound
pancratistatin
one
hypothes
compound
could
trigger
apoptosi
activ
fasassoci
destabil
mitochondria
jurkat
cell
previous
observ
griffin
et
al
mclachlan
et
al
signific
amount
work
must
done
delin
biochem
mechan
induct
apoptosi
compound
gener
melt
point
uncorrect
measur
gallenkamp
melt
point
apparatu
optic
rotat
determin
perkinelm
polarimet
instal
k
sodium
lamp
ir
spectra
measur
biorad
seri
spectromet
dri
film
cim
run
micromass
quattro
ultima
spectromet
fit
direct
inject
probe
dip
ioniz
energi
set
ev
hrm
ci
perform
micromass
qtof
ultima
spectromet
h
c
nmr
spectra
record
bruker
spectromet
cdcl
cd
od
tm
intern
standard
chemic
shift
report
unit
ppm
coupl
constant
j
express
hz
silica
gel
merck
mesh
use
cc
silica
gel
sil
guv
analyt
sil
prep
tlc
machereynagel
spot
chromatogram
detect
uv
light
nm
dragendorff
reagent
stain
lycorin
pseudolycorin
obtain
narcissu
bujei
previous
describ
us
labrana
et
al
voucher
specimen
deposit
herbarium
institut
botan
barcelona
spain
specimen
alkaloid
singl
compon
indic
nmr
hplc
analys
human
leukemia
jurkat
cancer
cell
purchas
atcc
manassa
va
cell
grown
maintain
incub
set
co
atmospher
rel
humid
media
sigmaaldrich
oakvil
supplement
fetal
bovin
serum
fb
lgml
gentamycin
life
technolog
mississauga
use
cell
cultur
explor
induct
apoptosi
lycoran
alkaloid
jurkat
cell
grown
treat
h
alkaloid
variou
concentr
alkaloid
dilut
cultur
media
mm
stock
dmso
rang
lm
use
apoptot
induct
alkaloid
treatment
calcul
control
treat
dmso
solvent
concentr
rel
alkaloid
treatment
nuclear
morpholog
chang
associ
apoptosi
visual
use
lm
final
concentr
cell
permeabl
hoechst
dye
molecular
probe
eugen
follow
treatment
variou
alkaloid
concentr
multipl
treatment
time
hoechst
dye
ad
directli
cultur
media
allow
incub
min
cell
examin
use
fluoresc
microscop
leica
dm
irb
germani
pictur
taken
object
obtain
apoptot
index
brightli
stain
condens
nuclei
apoptot
cell
count
minimum
field
contain
cell
minimum
total
cell
count
data
point
apoptot
index
creat
apoptot
cell
express
percentag
total
number
cell
count
statist
analysi
perform
use
statistica
data
three
separ
experi
p
obtain
alkaloid
lycorin
mg
mmol
dissolv
ml
dri
ch
cl
mlmmol
ad
dri
pyridin
ml
mmol
follow
tertbutyldimethylsilyl
chlorid
mg
mmol
solut
stir
room
temperatur
tlc
etoachexan
indic
consumpt
start
materi
h
mixtur
quench
satur
nh
cl
solut
ml
extract
ch
cl
ml
combin
organ
fraction
dri
anhydr
na
solvent
remov
reduc
pressur
crude
gum
obtain
subject
silica
gel
cc
give
offwhit
powder
synthesi
silyl
ether
mg
mmol
dissolv
room
temperatur
ml
ch
cl
mlmmol
ad
consecut
dri
pyridin
ml
mmol
ac
ml
mmol
solut
stir
h
tlc
etoachexan
indic
reaction
complet
mixtur
dilut
satd
nahco
solut
ml
extract
ch
cl
ml
combin
organ
fraction
dri
anhydr
na
solvent
remov
reduc
pressur
yield
gum
purifi
silica
gel
elut
etoachexan
give
compound
silyl
acet
mg
mmol
dissolv
room
temperatur
ml
dri
thf
mlmmol
ad
tetrabutylammonium
fluorid
tbaf
solut
ml
mmol
solut
left
stir
tlc
etoac
hexan
indic
reaction
complet
h
mixtur
dilut
satd
nh
cl
solut
ml
extract
etoac
ml
combin
organ
fraction
dri
anhydr
na
solvent
remov
reduc
pressur
yield
gum
purifi
silica
gel
column
elut
etoachexan
give
compound
light
yellow
crystallin
powder
synthesi
hydroxi
acet
mg
mmol
dissolv
room
temperatur
ml
ch
cl
mlmmol
ad
consecut
dri
pyridin
ml
mmol
ac
ml
mmol
solut
stir
h
tlc
etoachexan
indic
reaction
complet
mixtur
dilut
satd
nahco
solut
ml
extract
ch
cl
ml
combin
organ
fraction
dri
anhydr
na
solvent
remov
reduc
pressur
yield
gum
purifi
silica
gel
elut
etoachexan
give
compound
mg
white
crystallin
powder
mp
work
also
thank
dr
hugh
obtain
high
field
nmr
data
